 |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for MYB |
 Gene summary |
| Basic gene information | Gene symbol | MYB |
| Gene name | v-myb avian myeloblastosis viral oncogene homolog | |
| Synonyms | Cmyb|c-myb|c-myb_CDS|efg | |
| Cytomap | UCSC genome browser: 6q22-q23 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001130172.1, NM_001130173.1,NM_001161656.1,NM_001161657.1,NM_001161658.1, NM_001161659.1,NM_001161660.1,NM_005375.2, | |
| Description | c-myb protein (140 AA)c-myb10A_CDSc-myb13A_CDSc-myb14A_CDSc-myb8B_CDSproto-oncogene c-Mybtranscriptional activator Myb | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 189990 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000118513 | ||
| HPRD : 01810 | ||
| Vega : OTTHUMG00000015629 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_MYB | |
| BioGPS: 4602 | ||
| Pathway | NCI Pathway Interaction Database: MYB | |
| KEGG: MYB | ||
| REACTOME: MYB | ||
| Pathway Commons: MYB | ||
| Context | iHOP: MYB | |
| ligand binding site mutation search in PubMed: MYB | ||
| UCL Cancer Institute: MYB | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | TiGER,GTEx | |
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | BreastBone marrowTestis | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | BRCALAMLTGCT | |
| Reference showing the relevant tissue of MYB | ||
| Description by TissGene annotations | Protective TissGene in OS Cancer gene | |
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 10233885 | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 10233885 |
| Top |
| TissGeneExp for MYB |
| Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
 |
| Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
 |
| Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| BRCA | 3.31509089 | 1.903223346 | 1.411867544 | 3.50E-07 | 9.95E-07 |
| STAD | 1.746338204 | -0.883855546 | 2.63019375 | 4.24E-06 | 5.54E-05 |
| KIRC | -4.040267005 | -5.703736449 | 1.663469444 | 2.88E-12 | 1.19E-11 |
| PRAD | 0.535964405 | -0.49777021 | 1.033734615 | 1.24E-07 | 1.14E-06 |
| HNSC | -1.679517392 | -0.572017392 | -1.1075 | 0.00411 | 0.011388547 |
| ESCA | 1.359711783 | -2.055679126 | 3.415390909 | 0.000109 | 0.00341431 |
| KIRP | -4.427789921 | -5.780811796 | 1.353021875 | 8.98E-05 | 0.000310086 |
| BLCA | -0.283270514 | -2.229128408 | 1.945857895 | 1.86E-05 | 0.000306418 |
| Top |
| TissGene-miRNA for MYB |
| Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| Top |
| TissGeneMut for MYB |
| TissGeneSNV for MYB |
| nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
 |
 |
| Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
 |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.P31S | SKCM | 1 |
| p.R380K | SKCM | 1 |
| p.H24Y | LUAD | 1 |
| p.A264E | SARC | 1 |
| p.V478A | STAD | 1 |
| p.V503G | SKCM | 1 |
| p.T346I | SKCM | 1 |
| p.Q392R | READ | 1 |
| p.F412C | SKCM | 1 |
| p.P476Q | PAAD | 1 |
| p.G39A | LUSC | 1 |
| p.S744F | BLCA | 1 |
| p.G28V | COAD | 1 |
| p.V103A | BRCA | 1 |
| p.L456F | CESC | 1 |
| p.H283N | LIHC | 1 |
| p.A343S | LUSC | 1 |
| p.L396P | LIHC | 1 |
| p.S257G | UCEC | 1 |
| p.F415C | SKCM | 1 |
| p.G340E | UCEC | 1 |
| p.F591L | HNSC | 1 |
| p.E20G | LIHC | 1 |
| p.W63X | PRAD | 1 |
| p.T381I | SKCM | 1 |
| p.P642S | SKCM | 1 |
| p.L265F | ESCA | 1 |
| p.W43L | LUSC | 1 |
| p.S245F | SKCM | 1 |
| p.S304A | MESO | 1 |
| p.R337G | STAD | 1 |
| p.N705I | SKCM | 1 |
| p.A719S | UCEC | 1 |
| p.S623F | BLCA | 1 |
| p.E141Q | BLCA | 1 |
| p.G510E | BLCA | 1 |
| p.S542F | SKCM | 1 |
| p.R191Q | READ | 1 |
| p.A170T | READ | 1 |
| p.S473I | UCEC | 1 |
| p.H135Y | BRCA | 1 |
| p.S329N | LIHC | 1 |
| p.F411L | COAD | 1 |
| p.P379R | READ | 1 |
| p.I647S | BLCA | 1 |
| p.P731T | LUAD | 1 |
| p.S496I | PAAD | 1 |
| p.P112L | ESCA | 1 |
| p.W147* | BRCA | 1 |
| p.P233L | THYM | 1 |
| p.S342N | KIRC | 1 |
| p.E306K | BRCA | 1 |
| p.E437Q | BLCA | 1 |
| p.D18A | SKCM | 1 |
| p.S257C | LIHC | 1 |
| p.D62N | LUAD | 1 |
| p.R36C | STAD | 1 |
| p.A170T | ESCA | 1 |
| p.I269T | STAD | 1 |
| p.P262L | GBM | 1 |
| p.W63R | UCEC | 1 |
| p.L524V | BRCA | 1 |
| p.A264V | LGG | 1 |
| p.Q740H | ESCA | 1 |
| p.G362C | ESCA | 1 |
| p.R294* | BLCA | 1 |
| p.R586K | SKCM | 1 |
| p.G175R | LUSC | 1 |
| p.K645N | LUAD | 1 |
| p.S521L | SKCM | 1 |
| p.T60A | ESCA | 1 |
| p.P517L | SKCM | 1 |
| p.P610T | LUAD | 1 |
| p.P654S | UCEC | 1 |
| p.N525K | BRCA | 1 |
| p.V503I | DLBC | 1 |
| p.L690I | UCEC | 1 |
| p.P585L | SKCM | 1 |
| p.D618Y | LUSC | 1 |
| p.P555L | SKCM | 1 |
| p.P233S | SKCM | 1 |
| p.N271I | PRAD | 1 |
| p.L438M | SKCM | 1 |
| p.L644M | SKCM | 1 |
| p.G631E | BLCA | 1 |
| p.D670N | HNSC | 1 |
| p.L467F | HNSC | 1 |
| p.L301F | UCEC | 1 |
| p.W82R | LAML | 1 |
| p.R81Q | HNSC | 1 |
| p.E514Q | OV | 1 |
| Top |
| TissGeneCNV for MYB |
| Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
 |
| Top |
| TissGeneFusions for MYB |
| Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Chimerdb3.0 | ChiTaRs | NA | AA807457 | DNAJC1-MYB | chr10:22201941 | chr6:135540168 | |
| Chimerdb3.0 | ChiTaRs | NA | BE091998 | ACTG1-MYB | chr17:79479311 | chr6:135513463 | |
| Chimerdb3.0 | ChiTaRs | NA | BF332617 | ACTG1-MYB | chr17:79479141 | chr6:135513461 | |
| Chimerdb3.0 | ChiTaRs | NA | BE092001 | ACTG1-MYB | chr17:79479306 | chr6:135513463 | |
| Chimerdb3.0 | ChiTaRs | adeoid systic carcinoma;benign epithelial tumor | FJ969915 | MYB-NFIB | chr6:135524462 | chr9:14087937 | |
| Chimerdb3.0 | FusionScan | BRCA | TCGA-A1-A0SB-01A | MYB-NFIB | In-Frame | chr6:135521553 | chr9:14307519 |
| Chimerdb3.0 | TopHat-Fusion | BRCA | TCGA-A1-A0SB-01A | MYB-NFIB | In-Frame | chr6:135521552 | chr9:14307518 |
| TCGAfusionPortal | PRADA | BRCA | TCGA-A1-A0SB-01A | HEATR5B-MYB | Out-of-frame | Chr2:37215789 | Chr6:135522777 |
| TCGAfusionPortal | PRADA | BRCA | TCGA-A1-A0SB-01A | MYB-NFIB | In-frame | Chr6:135521553 | Chr9:14307519 |
| TCGAfusionPortal | PRADA | BRCA | TCGA-A2-A3XS-01A | AHI1-MYB | In-frame | Chr6:135679270 | Chr6:135539002 |
| TCGAfusionPortal | PRADA | BRCA | TCGA-EW-A1P3-01A | AIM1-MYB | NA | Chr6:106808956 | Chr6:135513462 |
| Top |
| TissGeneNet for MYB |
| Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| BRCA (tumor) | BRCA (normal) |
| MYB, NR3C1, CHD3, CEBPB, ETS1, MEN1, ASH2L, SDC2, NLK, SIN3A, RUNX1, FBXW5, MZF1, LEF1, KIT, ERC2, MAPK11, FBXL5, ADA, COX7B, NCAM2 (tumor) | MYB, CEBPB, ETS1, NCL, FLNA, CREBBP, NLK, BCL2, CLTA, SKP2, PML, SIN3A, MZF1, BIRC5, CCND3, FBXW2, GSTP1, FBXL5, ADA, COX7B, NCAM2 (normal) |
 |  |
| COAD (tumor) | COAD (normal) |
| MYB, NR3C1, UBC, RBBP5, MEN1, FLNA, MYC, CDK1, SDC2, NLK, MAF, SKP2, HLF, MYBBP1A, RUNX1, SKI, TTF2, PIAS1, BIRC5, ERC2, NCAM2 (tumor) | MYB, NR3C1, CHD3, ETS1, SP100, NCL, FLNA, MYC, CDK1, IRF1, MAF, PML, WDR5, RUNX1, SKI, TTF2, PIAS1, MAPK11, FBXL5, LIN9, PPM1K (normal) |
 |  |
| HNSC (tumor) | HNSC (normal) |
| MYB, NR3C1, ETS1, PCDH17, MEN1, CDK1, SDC2, BCL2, SKP2, CLTC, TTF2, FBXW5, BIRC5, ZMYND11, LEF1, NGFRAP1, KIF2A, GSTP1, NBPF14, ADAM22, ZFC3H1 (tumor) | MYB, CEBPB, SP100, SMARCA2, FLNA, ASH2L, MYC, CDK1, MAF, BCL2, IRF2, HLF, MED15, PARP1, TTF2, MZF1, LEF1, KIT, ERC2, LIN9, ADAM22 (normal) |
 |  |
| KICH (tumor) | KICH (normal) |
| MYB, ETS1, PCDH17, FLNA, PIN1, SDC2, CEBPE, MAF, PML, MED15, LYZ, FBXW7, RUNX1, SKI, PIAS1, NGFRAP1, PAX5, FBXW2, GSTP1, COX7B, PPM1K (tumor) | MYB, CHD3, UPF2, FLNA, CDK1, BCL2, SKP2, PARP1, RUNX1, SKI, TTF2, FBXW5, BIRC5, CCND3, KIT, KIF2A, LIN9, ZFHX3, ADA, NBPF14, NCAM2 (normal) |
 |  |
| KIRC (tumor) | KIRC (normal) |
| MYB, CEBPB, ETS1, SMARCA2, PCDH17, FLNA, ASH2L, MYC, CEBPE, MAF, UBE2I, SKP2, LYZ, RUNX1, BIRC5, LEF1, NGFRAP1, PAX5, ADA, COX7B, PPM1K (tumor) | MYB, SUMO2, CHD3, CEBPB, SP100, MAPK1, CDK1, SDC2, IRF1, IRF2, PML, LYZ, FBXW7, RUNX1, TTF2, BIRC5, NGFRAP1, PAX5, ADA, ZFC3H1, PPM1K (normal) |
 |  |
| KIRP (tumor) | KIRP (normal) |
| MYB, ETS1, MAPK1, FLNA, CEBPE, UBE2I, IRF2, PML, MED15, LYZ, MYBBP1A, FBXW7, RUNX1, BIRC5, ZMYND11, LEF1, NGFRAP1, PAX5, ADA, COX7B, PPM1K (tumor) | MYB, SUMO2, CEBPB, ETS1, CDK1, IRF1, MAF, FBXW7, RUNX1, SKI, MZF1, BIRC5, CCND3, LEF1, NGFRAP1, PAX5, KIT, FBXL5, LIN9, COX7B, PPM1K (normal) |
 |  |
| LIHC (tumor) | LIHC (normal) |
| MYB, TRAF6, SUMO2, CHD3, ETS1, PCDH17, PIN1, CDK1, NLK, BCL2, WDR5, CLTC, FBXW7, SIN3A, TTF2, FBXW5, ZMYND11, RQCD1, KIF2A, MYOZ2, ZFHX3 (tumor) | MYB, NR3C1, SUMO2, CHD3, CDK1, SDC2, IRF1, UBE2I, SKP2, PML, HLF, MED15, TRIM28, RUNX1, TTF2, BIRC5, KIF2A, FBXL5, LIN9, ADA, ADAM22 (normal) |
 |  |
| LUAD (tumor) | LUAD (normal) |
| MYB, CSNK2A1, ETS1, SMARCA2, UPF2, MEN1, SETD1A, MYC, SDC2, IRF1, SKP2, WDR5, MYBBP1A, IL4, SIN3A, TTF2, MZF1, CCND3, ERC2, KIF2A, ADAM22 (tumor) | MYB, NR3C1, UBC, UPF2, ASH2L, CDK1, BCL2, SKP2, WDR5, SP3, PARP1, TTF2, FBXW5, BIRC5, CCND3, RQCD1, KIF2A, FBXL5, LIN9, ADAM22, TRHR (normal) |
 |  |
| LUSC (tumor) | LUSC (normal) |
| MYB, UBC, SP100, SMARCA2, UPF2, MEN1, ASH2L, MYC, SDC2, IRF1, NLK, IRF2, SKP2, SP3, LYZ, PIAS1, IL13, RQCD1, KIF2A, LIN9, PPM1K (tumor) | MYB, HIPK2, CEBPB, SMARCA2, UPF2, RBBP5, NLK, MAF, BCL2, HLF, SIN3A, PARP1, TTF2, PIAS1, KIT, ERC2, LIN9, MYOZ2, ZFHX3, ADAM22, TRHR (normal) |
 |  |
| PRAD (tumor) | PRAD (normal) |
| MYB, SMARCA2, FLNA, MYC, SDC2, IRF1, NLK, WDR5, SPTAN1, LYZ, FBXW7, RUNX1, PIAS1, BIRC5, LEF1, NGFRAP1, KIT, ERC2, GSTP1, LIN9, ZFHX3 (tumor) | MYB, UBC, UPF2, SUMO1, PIN1, MYC, SKP2, LYZ, FBXW7, PARP1, TTF2, PIAS1, CCND3, LEF1, NGFRAP1, PAX5, MAPK11, FBXL5, LIN9, ZFHX3, COX7B (normal) |
 |  |
| STAD (tumor) | STAD (normal) |
| MYB, SMARCA2, MEN1, FLNA, CDK1, SDC2, HLF, RUNX1, TTF2, BIRC5, ZMYND11, SND1, LEF1, NGFRAP1, ERC2, FBXL5, MYOZ2, ZFHX3, PTMS, PPM1K, NCAM2 (tumor) | MYB, NR3C1, UBC, NCOR1, NCL, FLNA, MYC, CDK1, SDC2, IRF1, MAF, SKP2, WDR5, TTF2, BIRC5, NGFRAP1, KIF2A, MAPK11, FBXL5, LIN9, MYOZ2 (normal) |
 |  |
| THCA (tumor) | THCA (normal) |
| MYB, ETS1, SP100, CDK1, SDC2, CEBPE, IRF1, MED15, LYZ, FBXW7, PARP1, RUNX1, BIRC5, ZMYND11, CCND3, LEF1, PAX5, KIT, MAPK11, FBXL5, ADA (tumor) | MYB, SP100, FLNA, MYC, CDK1, IRF1, BCL2, HLF, MED15, LYZ, RUNX1, TTF2, MZF1, BIRC5, ZMYND11, NGFRAP1, PAX5, ERC2, KIF2A, FBXL5, NCAM2 (normal) |
 |  |
| Top |
| TissGeneProg for MYB |
| Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
 |
| Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Top |
| TissGeneClin for MYB |
| TissGeneDrug for MYB |
| Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for MYB |
| Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
| umls:C0010606 | Adenoid Cystic Carcinoma | 23 | BeFree,CTD_human |
| umls:C0023418 | leukemia | 13 | BeFree,LHGDN |
| umls:C0175754 | Agenesis of corpus callosum | 13 | BeFree |
| umls:C0006142 | Malignant neoplasm of breast | 11 | BeFree |
| umls:C0678222 | Breast Carcinoma | 11 | BeFree |
| umls:C0002895 | Anemia, Sickle Cell | 8 | BeFree,GAD |
| umls:C0023467 | Leukemia, Myelocytic, Acute | 8 | BeFree |
| umls:C0025202 | melanoma | 7 | BeFree |
| umls:C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 7 | BeFree,CTD_human |
| umls:C0005283 | beta Thalassemia | 5 | BeFree,GAD |
| umls:C0598766 | Leukemogenesis | 5 | BeFree |
| umls:C1458155 | Mammary Neoplasms | 5 | BeFree |
| umls:C0009375 | Colonic Neoplasms | 4 | BeFree,LHGDN |
| umls:C0023473 | Myeloid Leukemia, Chronic | 4 | BeFree |
| umls:C0024299 | Lymphoma | 4 | BeFree |
| umls:C0027819 | Neuroblastoma | 4 | BeFree |
| umls:C0700095 | Central neuroblastoma | 4 | BeFree |
| umls:C1527249 | Colorectal Cancer | 4 | BeFree |
| umls:C0002312 | alpha-Thalassemia | 3 | BeFree,GAD |
| umls:C0004096 | Asthma | 3 | BeFree,CTD_human,GAD |
| umls:C0005699 | Blast Phase | 3 | BeFree,LHGDN |
| umls:C0007102 | Malignant tumor of colon | 3 | BeFree |
| umls:C0009402 | Colorectal Carcinoma | 3 | BeFree |
| umls:C0017638 | Glioma | 3 | BeFree,CTD_human |
| umls:C0085669 | Acute leukemia | 3 | BeFree |
| umls:C0596263 | Carcinogenesis | 3 | BeFree |
| umls:C0001815 | Primary Myelofibrosis | 2 | BeFree |
| umls:C0018790 | Cardiac Arrest | 2 | BeFree |
| umls:C0023449 | Acute lymphocytic leukemia | 2 | BeFree |
| umls:C0023470 | Myeloid Leukemia | 2 | BeFree,LHGDN |
| umls:C0023492 | Leukemia, T-Cell | 2 | BeFree |
| umls:C0023493 | Adult T-Cell Lymphoma/Leukemia | 2 | BeFree |
| umls:C0027022 | Myeloproliferative disease | 2 | BeFree,LHGDN |
| umls:C0027627 | Neoplasm Metastasis | 2 | BeFree |
| umls:C0178874 | Tumor Progression | 2 | BeFree |
| umls:C0679427 | myeloblastosis | 2 | BeFree |
| umls:C0699790 | Colon Carcinoma | 2 | BeFree |
| umls:C1368683 | Epithelioma | 2 | BeFree |
| umls:C1456873 | alpha^+^ Thalassemia | 2 | BeFree |
| umls:C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2 | BeFree,LHGDN |
| umls:C0003857 | Congenital arteriovenous malformation | 1 | BeFree |
| umls:C0004114 | Astrocytoma | 1 | BeFree |
| umls:C0007124 | Noninfiltrating Intraductal Carcinoma | 1 | BeFree |
| umls:C0007131 | Non-Small Cell Lung Carcinoma | 1 | BeFree |
| umls:C0008626 | Congenital chromosomal disease | 1 | BeFree |
| umls:C0010054 | Coronary Arteriosclerosis | 1 | BeFree |
| umls:C0010068 | Coronary heart disease | 1 | BeFree |
| umls:C0014457 | Eosinophilia | 1 | BeFree |
| umls:C0017636 | Glioblastoma | 1 | BeFree |
| umls:C0020538 | Hypertensive disease | 1 | GAD |
| umls:C0023440 | Acute Erythroblastic Leukemia | 1 | LHGDN |
| umls:C0023448 | Lymphoid leukemia | 1 | BeFree |
| umls:C0023480 | Leukemia, Myelomonocytic, Chronic | 1 | BeFree |
| umls:C0024530 | Malaria | 1 | BeFree |
| umls:C0027051 | Myocardial Infarction | 1 | GAD |
| umls:C0027430 | Nasal Polyps | 1 | GAD |
| umls:C0027962 | Melanocytic nevus | 1 | BeFree |
| umls:C0028754 | Obesity | 1 | GAD |
| umls:C0030193 | Pain | 1 | GAD |
| umls:C0032000 | Pituitary Adenoma | 1 | BeFree |
| umls:C0033027 | Preleukemia | 1 | BeFree |
| umls:C0036095 | Salivary Gland Neoplasms | 1 | BeFree |
| umls:C0036421 | Systemic Scleroderma | 1 | BeFree |
| umls:C0037054 | Sickle Cell Trait | 1 | BeFree |
| umls:C0039730 | Thalassemia | 1 | GAD |
| umls:C0079773 | Lymphoma, T-Cell, Cutaneous | 1 | BeFree |
| umls:C0085096 | Peripheral Vascular Diseases | 1 | GAD |
| umls:C0085207 | Gestational Diabetes | 1 | BeFree |
| umls:C0151779 | Cutaneous Melanoma | 1 | BeFree |
| umls:C0155877 | Allergic asthma | 1 | BeFree |
| umls:C0206692 | Carcinoma, Lobular | 1 | BeFree |
| umls:C0264408 | Childhood asthma | 1 | BeFree |
| umls:C0279751 | Adenoid cystic carcinoma of salivary gland | 1 | BeFree |
| umls:C0280100 | Solid tumour | 1 | BeFree |
| umls:C0334533 | Arteriovenous hemangioma | 1 | BeFree |
| umls:C0334583 | Pilocytic Astrocytoma | 1 | BeFree |
| umls:C0376544 | Hematopoietic Neoplasms | 1 | BeFree |
| umls:C0518014 | Hematocrit level | 1 | GAD |
| umls:C0600139 | Prostate carcinoma | 1 | BeFree |
| umls:C1176475 | Ductal Carcinoma | 1 | BeFree |
| umls:C1261502 | Finding of Mean Corpuscular Hemoglobin | 1 | GAD |
| umls:C1266086 | Polymorphous low grade adenocarcinoma | 1 | BeFree |
| umls:C1292778 | Chronic myeloproliferative disorder | 1 | BeFree |
| umls:C1305968 | Eccrine dermal cylindroma | 1 | BeFree |
| umls:C1306759 | Eosinophilic disorder | 1 | BeFree |
| umls:C1332167 | Adenoid cystic breast carcinoma | 1 | BeFree |
| umls:C1336076 | Sporadic Breast Carcinoma | 1 | BeFree |
| umls:C1636667 | Disorder characterized by eosinophilia | 1 | BeFree |
| umls:C1956346 | Coronary Artery Disease | 1 | BeFree |
| umls:C3463824 | MYELODYSPLASTIC SYNDROME | 1 | BeFree |
| umls:C3811653 | Experimental Organism Basal Cell Carcinoma | 1 | BeFree |
| umls:C0023437 | Acute Basophilic Leukemia | 0 | ORPHANET |
| umls:C0026987 | Myelofibrosis | 0 | MGD |
Copyright 2016-Present - The University of Texas Health Science Center at Houston (UTHealth) Web File Viewing | How to Report, Fraud, Waste and Abuse | State of Texas | Statewide Search | Texas Homeland Security | Site Policies |